(Reuters) – Johnson & Johnson said on Friday it has resumed the limited market release of its Varipulse heart device in the United States after an investigation found the devices operate as intended.
In January, the company had paused the heart device, a pulsed field ablation system, citing an abundance of caution as it investigated four reported stroke events.
(Reporting by Mrinmay Dey in Bengaluru; Editing by William Mallard)
Comments